Momenta Files Patent Infringement Lawsuit against Mylan
shot by IP News Shots / 2:54 pm on 27 May, 2022
Momenta Pharmaceuticals Inc. filed a two-count patent infringement case in the U.S. District Court for the Western District of Pennsylvania targeting not only Mylan NV — which is now part of Viatris Inc. — but also Natco Pharma Ltd. and Gland Pharma Ltd. , which are companies based out of India. As per the lawsuit, Mylan has been imitating patented manufacturing methods to make a generic version of multiple sclerosis treatment.
Industry: Pharmaceuticals | News Category: Litigations | Type of IP: Patent
Read more at Law360
Leo Pharma and Glenmark Pharma Resolves Enstilar Psoriasis Drug Patent Suit
shot by IP News Shots / 12:50 am on 30 April, 2022
Leo Pharma A/S and Glenmark Pharmaceuticals Ltd. have agreed to settle their Enstilar Psoriasis drug patent suit in the U.S. District Court for the District of Delaware. As per the terms of the settlement agreement, Glenmark is barred from making copies of the drug until the patents have expired. Leo had sued Glenmark in 2020 alleging that its proposed copycat infringes five patents for Enstilar that were issued earlier that year.
Industry: Pharmaceuticals | News Category: Litigations | Type of IP: Patent
Read more at Bloomberg Law
Alcon Files Lawsuit Over Eye Allergy Patent Infringement in a Delaware Court
shot by IP News Shots / 12:45 am on 30 April, 2022
Alcon Inc. and Alcon Laboratories Inc. have filed a patent infringement lawsuit over Pataday eye allergy treatment in U.S. District Court for the District of Delaware. Alcon requested for an injunction that would prohibit Somerset Therapeutics LLC, Somerset Pharmaceuticals, Inc. and Odin Pharmaceuticals, LLC from selling the proposed generic version of Alcon’s Pataday.
Industry: Healthcare Technology, Pharmaceuticals | News Category: Litigations | Type of IP: Patent
Read more at Law360
Arbor, Lupin Settles Patent Lawsuit Over Planned Blood Pressure Generic
shot by IP News Shots / 2:00 pm on 22 April, 2022
The U.S. District Court for the District of Delaware has dismissed the patent infringement charges brought by Arbor Pharmaceuticals LLC and Takeda Pharmaceutical Co. Ltd. against Lupin Ltd. The lawsuit was related to planned blood pressure generic.
Industry: Pharmaceuticals | News Category: Litigations | Type of IP: Patent
Read more at Law360
Sandoz Wins the Battle to Block its Generic Lung-Disease Drug from Roche
shot by IP News Shots / 12:12 pm on 26 March, 2022
Roche Genentech Inc. lost its bid to block Sandoz Inc.’s generic lung-disease drug. Sandoz was successful in persuading a Delaware Federal Judge to dismiss the lawsuit filed by Roche as there was no case of patent infringement as alleged by Roche. The judge rejected the Roche’s claims and found parts of the patent to be invalid.
Industry: Pharmaceuticals | News Category: Litigations | Type of IP: Patent
Read more at Reuters
A Texas Court Dismisses Patent Infringement Charges Against GW Pharmaceuticals
shot by IP News Shots / 4:43 pm on 04 March, 2022
The U.S. District Court for the Western District of Texas dismissed patent infringement charges against GW Pharmaceuticals PLC by Canopy Growth Corp. The court agreed that Canopy Growth failed to prove its claim of infringement related to the flagship CBD drug Epidiolex under the doctrine of equivalents.
Industry: Pharmaceuticals | News Category: Litigations | Type of IP: Patent
Read more at Law360